STOP-HSP.Net: a Registry for Hereditary Spastic Paraplegia as an Integration Tool for Future Therapeutic Strategies

Abroad (travel likely)Recruiting

Conditions

Hereditary Spastic Paraplegia

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

IRCCS Fondazione Stella Maris, Pisa, Italy
Contact: Study coordinator (Filippo M Santorelli, Dr.) · filippo.santorelli@fsm.unipi.it · +39 050886275
Contact: Study coordinator (Sara Satolli, Dr.) · sara.satolli@fsm.unipi.it

Study leads

Filippo M Santorelli, Dr.
Principal Investigator
IRCCS Fondazione Stella Maris

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Melpida: Recombinant Adeno-associated Virus (Serotype 9) Encoding a Codon Optimized Human AP4M1 Transgene (hAP4M1opt)

Spasticity, Muscle · Microcephaly · Intellectual Deficiency

Abroad (travel likely)RecruitingPHASE1, PHASE2

Dallas, United States

Neuromodulation to Enhance Motor Function in HSP

Hereditary Spastic Paraplegia

Abroad (travel likely)Recruiting

Lexington, United States

Phase 3 Efficacy Study With Concurrent Control of IT MELPIDA in SPG50.Concurrent Controls.

Hereditary Spastic Paraplegia Type 50

Abroad (travel likely)RecruitingPHASE3

Dallas, United States · Barcelona, Spain

Registry and Natural History Study for Early Onset Hereditary Spastic Paraplegia

Hereditary Spastic Paraplegia · SPG47 · SPG50

Abroad (travel likely)Recruiting

Boston, United States